Recro Pharma, Inc. (NASDAQ:REPH) Receives Average Recommendation of "Buy" from Brokerages

Retrieved on: 2021-01-04 14:26:30

Tags for this article:

Click the tags to see associated articles and topics

Recro Pharma, Inc. (NASDAQ:REPH) Receives Average Recommendation of "Buy" from Brokerages. View article details on hiswai:

Excerpt

Finally, WINTON GROUP Ltd purchased a new position in Recro Pharma during the third quarter valued at approximately $63,000. Institutional ...

Article found on: www.marketbeat.com